Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 5, Issue 8, Page 1 (November 2009)


View previous. 2 of 17 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (188 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

Botulinum Toxin Reduced Migraine Frequency in Trials: Treatment-related adverse events reported.

MICHELE G. SULLIVAN

PHILADELPHIA — OnabotulinumtoxinA appears to be a safe, effective, and well-tolerated headache prophylactic for patients with chronic migraine.

PII: S1553-3212(09)70168-2

doi:10.1016/S1553-3212(09)70168-2


View previous. 2 of 17 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.